RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of EVOK
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Volatile ride for Evoke Pharma stock price on Wednesday moving between $0.571 and $0.640
(Updated on Mar 27, 2024)

Sell candidate since Mar 15, 2024 Loss -5.35% PDF

The Evoke Pharma stock price fell by -2.96% on the last day (Wednesday, 27th Mar 2024) from $0.605 to $0.587. During the last trading day the stock fluctuated 12.03% from a day low at $0.571 to a day high of $0.640. The price has fallen in 6 of the last 10 days and is down by -8.46% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -6 thousand shares and in total, 18 thousand shares were bought and sold for approximately $10.34 thousand.

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $0.626 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -35.81% during the next 3 months and, with a 90% probability hold a price between $0.254 and $0.402 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

EVOK Signals & Forecast

There are few to no technical positive signals at the moment. The Evoke Pharma stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.597 and $0.652. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, March 08, 2024, and so far it has fallen -16.17%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Evoke Pharma stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0687 between high and low, or 12.03%. For the last week the stock has had daily average volatility of 9.79%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (EVOK) For The Upcoming Trading Day Of Thursday 28th

For the upcoming trading day on Thursday, 28th we expect Evoke Pharma to open at $0.599, and during the day (based on 14 day Average True Range), to move between $0.519 and $0.654, which gives a possible trading interval of +/-$0.0673 (+/-11.47%) up or down from last closing price. If Evoke Pharma takes out the full calculated possible swing range there will be an estimated 22.94% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $0.620, some $0.0332 (5.66%) from the current price of $0.587, our system finds the risk reward not very attractive.

Is Evoke Pharma stock A Buy?

Evoke Pharma holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.372 Sell Candidate Unchanged

Predicted Opening Price for Evoke Pharma of Thursday, March 28, 2024

Fair opening price March 28, 2024 Current price
$0.599 ( 2.14%) $0.587

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for EVOK

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.668 13.85 %
R2 0.642 9.38 %
R1 0.626 6.61 %
Current price: 0.587
Support S1 0.573 -2.33 %
S2 0.557 -5.09 %
S3 0.531 -9.57 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.710 21.00 %
R2 0.700 19.29 %
R1 0.620 5.66 %
Current price 0.587
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for Evoke Pharma Stock and on which exchange is it traded?
The symbol for Evoke Pharma is EVOK and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Evoke Pharma Stock?
Evoke Pharma holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Evoke Pharma Stock?
Evoke Pharma Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Evoke Pharma Stock.

What's the current price of Evoke Pharma Stock?
As of the end of day on the 2024-03-27, the price of an Evoke Pharma (EVOK) share was $0.587.

What is the 52-week high and low for Evoke Pharma Stock?
The 52-week high for Evoke Pharma Stock is $2.42 and the 52-week low is $0.558.

What is the market capitalization of Evoke Pharma Stock?
As of the 2024-03-27, the market capitalization of Evoke Pharma is 4.975M.

When is the next earnings date for Evoke Pharma?
The upcoming earnings date for Evoke Pharma is May 13, 2024.
Click to get the best stock tips daily for free!

About Evoke Pharma

Evoke Pharma Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine ... EVOK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT